Treffer 1 - 3 von 3 für Suche 'Kolanian, A.', Suchdauer: 0,27s Treffer weiter einschränken
  1. 1
    PCN127 NUMBER NEEDED TO TREAT (NNT) AND COST OF PREVENTING AN EVENT (COPE) COMPARISON BETWEEN THE TRIPLETS DRD AND KRD FOR RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA IN THE BRAZILIAN PRIVATE SYSTEM

    PCN127 NUMBER NEEDED TO TREAT (NNT) AND COST OF PREVENTING AN EVENT (COPE) COMPARISON BETWEEN THE TRIPLETS DRD AND KRD FOR RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA IN THE BRAZILI... von Decimoni, T., Kolanian, A., Fioratti, C., Brunelli, M.J.

    Veröffentlicht in Value in health

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    PRO12 LITERATURE REVIEW OF CHALLENGES AND OPPORTUNITIES IN HEALTH ECONOMIC EVALUATION METHODOLOGY IN RARE DISEASES

    PRO12 LITERATURE REVIEW OF CHALLENGES AND OPPORTUNITIES IN HEALTH ECONOMIC EVALUATION METHODOLOGY IN RARE DISEASES von Decimoni, T., Piedade, A., Fioratti, C., Fumagalli, S., Foli, D., Kolanian, A., Brunelli, M.J.

    Veröffentlicht in Value in health regional issues

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Cost per Progression Free Survival (PFS) of Daratumumab, Elotuzumab, Carfilzomib and Ixazomib Combinations with Lenalidomide/Dexamethasone (DRd, ERd, KRd, IRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

    Cost per Progression Free Survival (PFS) of Daratumumab, Elotuzumab, Carfilzomib and Ixazomib Combinations with Lenalidomide/Dexamethasone (DRd, ERd, KRd, IRd) in Patients with Rel... von Santana, Pamela, Saad, Ricardo, Kolanian, Adrielle, Fioratti, Cyntia, Junqueira, Marcela, Decimoni, Tassia

    Veröffentlicht in Blood

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: